HOME
ORGANIZING COMMITTEE
GENERAL INFORMATION
INVITED SPEAKERS AND CHAIRMEN
PRELIMINARY PROGRAM
POSTER PRESENTATION
REGISTRATION FORM

THURSDAY MORNING
THURSDAY AFTERNOON
FRIDAY MORNING
FRIDAY AFTERNOON
SATURDAY MORNING

PRELIMINARY PROGRAM

THURSDAY APRIL 18, 2002 - MORNING

ROOM "SAN GIOVANNI"

8.30 a.m.	OPENING CEREMONY
9.00 a.m.	Introduction. E. Mannarino
9.30 a.m.	WORKSHOP: Inflammation, oxidative stress and atherothrombosis
	Chairmen: H. Sinzinger, G. Nenci
	Oxidative stress and atherosclerosis, F. Violi
	Lipid peroxidation, inflammation and platelet activation: a link between risk factors and atherothrombosis, G. Davì
	Tissue factor and atherothrombosis, E. Tremoli
	Acute phase proteins and cardiovascular risk, M. Pirro
11.00 a.m.	Discussion
11.30 a.m.	coffee break
11.45 a.m.	Round table: Prevention and therapy of venous thromboembolism in the oncologic and surgical patient
	Chairmen: E. Mannarino, A. Notarbartolo
	Unsolved issues in the prevention of venous thromboembolism, G. Agnelli
	Venous thromboembolism in the oncologic patient, L. Crinò
	Venous thromboembolism in the surgical patient, F. Sciannameo
	Venous thromboembolism in the orthopedical patient, G. Cerulli
	Venous thromboembolism in the gynecological patient, G. Brusco
1.00 a.m.	Discussion
1.30 p.m.	Lunch break

THURSDAY APRIL 18, 2002 - AFTERNOON

2.30 p.m.	WORKSHOP: New insights in endothelial function and in thrombosis
	Chairmen: F. Violi, L.Pasqualini
	Nitric oxide as a natural antithrombotic agent, P.Gresele
	Markers of endothelial dysfunction, S. Marchesi
	Lipid modulation of endothelial function, G. Lupattelli
	Hemorheology and atherothrombosis,G. Ciuffetti
3.50 p.m.	Discussion
4.15 p.m.	Round table: Prevention and therapy of venous thromboembolism in Internal medicine
	Chairmen: E. Mannarino, F. Santeusanio
	Venous thromboembolism: an update, L. Pasqualini
	Prophylaxis in medical patients: implications of the MEDENOX study results, M. Pini
	Translating research into practice: the home treatment of VTE, M. Moia
5.20 p.m.	Discussion
5.45 p.m. - 7.00 p.m.	Poster exhibition
7.00 p.m. - 7.30 p.m.	Assembly of Members of Danubian League

FRIDAY APRIL 19, 2002 - MORNING

ROOM "SAN GIOVANNI"

9.00 a.m.	WORKSHOP: Cardiovascular diseases - diagnosis and therapy
	Chairman: A. Puxeddu, F. Grignani
	Brain Natriuretic Peptide and myocardial damage, B. Palumbo, R. Palumbo
	Antihypertensive treatment and prevention of cardiovascular disease: an evidence-based approach, G. Schillaci
	Beta-blockers in heart failure, M. Cocchieri
	Thrombolytic actions of statins and of ACE inhibitors, R. Gryglewski
10.20 a.m.	Discussion
10.40 a.m.	Coffee break
11.00 a.m.	Lecture
	Chairmen: C.Riccardi, R. Gryglewski
	Economy class syndrome: myths and facts, H. Sinzinger
11.30 a.m.	Nursing and management of the surgical and orthopedical patient, A. Rossi
11.50 a.m.	Oral communications
	Chairmen: G. Davì, F. Markwardt
	Genetic polymorphisms and thrombosis risk of cerebrovascular ischemic disorders at young age D. De Lucia, G. Maisto, R.Marotta, M. Mosavat, S. Carannante, G. Sica, V. Del Giudice, A. Gregnuoli, F. De Francesco, M. Fratta , M. Quarantiello , M.L. Papa , A.M. Terracciano, B. Ronga
	The prevalence of combined prothrombotic polymorphisms in young survivors of myocardial infarction K. Lewandowski, A. Swierczynska, P. Kwasnikowski, W. Elikowski, K. Zawilska
	Prevalence of factor V Leiden, 20210GA Prothrombin and C677T MTHFR mutations among patients with peripheral occlusive diseases in the North-Western Russia N. Saltikova, V. Shmeleva, S. Kapustin
	Genetic analysis of hereditary protein C deficiency in Hungarian patients with thromboembolic diseaes M. Dávid, H. Losonczy, Á. Nagy, O. Tóth, G. Kutscher, B. Meng, M. Meyer
	Greifswald registry of factor X congenital deficiency gly222asp and ser379lys - novel factor X gene mutations in severe FX deficiency F.H. Herrmann, K. Wulff, S. Lopaciuk, H. Pollmann
	Prevalence and clinical significance of single and combined abnormalities predisposing to venous thromboembolism in familiar thrombophilias H. Losonczy, Á. Nagy, M. Dávid, T. Vidra, O. Tóth, M. Kecskés, Á. Szomor
	Plasmin induces MCP-1 and CD40 gene expression in human peripheral monocytes via activation of JAK/STAT and p38 MAPK signaling pathways L. Burysek, T. Syrovets, T. Simmet
1.00 p.m.	Lunch break

FRIDAY APRIL 19, 2002 - AFTERNOON

2.00 p.m.	Round table: Low molecular weight heparins
	Chairmen: E. Mannarino, L.Casali
	Introduction, E. Mannarino
	Low molecular weight heparins in pulmonary embolism, G.Vaudo
	The use of low molecular weight heparin in acute coronary syndromes, C. Giombolini
	Low molecular weight heparins in arthroscopy, G. Tavolieri
3.00 p.m.	Discussion
3.20 p.m. - 6.00 p.m.	Oral Communications
	Chairmen: H. Sinzinger, G.Ambrosio
	Objective endpoints in clinical trials on patients with acute DVT H.K. Breddin, V.V. Kakkar, Z. Kadziola, M. Scully, R. Nakov
	Molecular thrombophilic abnormalities and thrombotic recurrence I.N. Bokarev, T.V. Kozlova, L.I. Patrushev, V.S. Efimov
	Studies on the effect of naturally occurring humic acids and synthetic humic Acid-like polymers on plasma protein C activity H.-P. Klöcking, N. Mahr, K.-H. Heise, R. Klöcking
	Emergency bleeding from the gastrointestinal tract: the role of anticoagulants and other drugs as precipitating factors Krc I., Procházka V., Vinklerová I., Krcová V., Jakubec P.
	Hemophilia in Costa Rica C. Montero
	Increased TGF-b circulating levels and production in human monocytes after HMG-CoA reductase inhibition with Pravastatin G. Baccante, C. Di Febbo, M. DI Nisio, A. AngelinI, F. Cuccurullo, E. Porreca
	Variable response of isoprostanes during statin therapy H. Sinzinger, A. Oguogho
	Troglitazone inhibits glycation and oxidation of native and modified LDL G. Sobal, J. Menzel, H. Sinzinger
	Modulation of HDL-oxidation by thyroid hormonal status U. Resch, F. Tatzber, H. Sinzinger
	Haemodynamic of carotid vessels in normal subjects D. Pieragalli, V. De Franco, S. Panti, S. De Candia, S. Meini, E. Castellano, A. Auteri, C. Setacci
	Haemodynamic changes in stenosis of extracranial internal carotid arteries V. De Franco, D. Pieragalli, S. Panti, S. De Candia, S. Meini, E. Castellano, A. Auteri, C. Setacci
	The examination of endothelial dysfunction using combination of endothelial markers P. Galajda, AD. Blann, l. Sutarik, J. Stasko, M. Ochodnicky, l. Dulikova, B. Raska, P. Kubisz, M. Mokan
	Acute myocardial infarction and cerebrovascular accident in a man after a viper bite: a case report S. Notaristefano, A. Notaristefano
	Effects of short-term energy restriction and physical training on risk factors for coronary heart disease in obese children and adolescents S. Gallistl, K.M. Sudi, M. Borkenstein, W. Muntean
6.15 p.m. - 7.15 p.m.	National Committee Meeting

SATURDAY APRIL 20, 2002 - MORNING

8.30 a.m.	Lecture
	Chairman E. Mannarino
	Aspirin: which role in primary prevention? R. Landolfi
9.00 a.m.	WORKSHOP: Prevention and therapy of thrombosis
	Chairman: E. Wenzel, O Ulutin
	The role of 13-HODE (13-hydroperoxyoctadecadienoic acid) in the prevention and diagnosis of cardiovascular disease, M. Buchanan
	The risks and benefits of Hormone Replacement Therapy in women with cardiovascular disease: a North American prospective, S. Brister
	Perspectives in the development of thrombin inhibitors, F. Markwardt
	Modern problems of thrombolysis in patients with myocardial infarction, I. Bokarev
10.20 a.m.	Discussion
10.40 a.m.	Coffee break
11.00 a.m.	Symposium: Hemostasis in the neonate
	Chairmen: W. Muntean, M. Ries
	Introduction, W. Muntean
	Thrombin generation, G. Cvirn
	Fibrinolysis, M. Ries
	Primary hemostasis, B. Großhaupt, B. Roschitz
	The use of low molecular weight heparin (enoxaparin) in newborn infants: a prospective cohort study of 62 patients, W. Streif, P. Massicotte, G. Goebel, M. Andrew
	Antiphospholipid antibodies in the neonate, Ch. Male, l. Mitchell, G. de Veber
12.30 p.m.	Discussion
1.00 p.m.	Conclusions

ORGANIZING AGENCY

CONSULTA UMBRIA
Piazza Italia, 9
06121 Perugia, ITALY
Tel +39 075 5720608
Fax +39 075 5721913
congressi@consultaumbria.com